We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
(+4.6%)
Cap. Flow
-$5.41B
Cap. Flow
% of AUM
-23.63%
Top 10 Holdings %
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$41.8M |
| 2 |
Apple
AAPL
|
+$35.4M |
| 3 |
Amazon
AMZN
|
+$34.6M |
| 4 |
AESC
The AES Corporation
AESC
|
+$30.3M |
| 5 |
Adobe
ADBE
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$236M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$31.2M |
| 3 |
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
|
+$25M |
| 4 |
Applied Materials
AMAT
|
+$22.1M |
| 5 |
Baxter International
BAX
|
+$20.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Financials | 8.11% |
| 3 | Healthcare | 7.32% |
| 4 | Consumer Discretionary | 6.91% |
| 5 | Communication Services | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
HDFC Bank
HDB
$121B
| $10.8M | 0.05% |
294,764
+2,744
| +0.9% | +$102K |
|
277
Archer Daniels Midland
ADM
$40.1B
| $10.6M | 0.05% |
176,493
+15,381
| +10% | +$922K |
|
278
Pentair
PNR
$10.8B
| $10.5M | 0.05% |
145,211
+12,473
| +9% | +$931K |
|
279
TE Connectivity
TEL
$62.1B
| $10.4M | 0.05% |
76,066
+6,712
| +10% | +$969K |
|
|
ZEN
280
CALL
DELISTED
ZENDESK INC
ZEN
| $10.3M | 0.05% |
+88,500
| New | +$11.4M |
|
281
Quest Diagnostics
DGX
$26B
| $10.3M | 0.04% |
70,712
+6,239
| +10% | +$913K |
|
282
SLM Corp
SLM
$4.74B
| $10.2M | 0.04% |
581,355
-203,852
| -26% | -$3.83M |
|
283
Kroger
KR
$36.3B
| $10.2M | 0.04% |
251,879
+22,226
| +10% | +$933K |
|
284
General Dynamics
GD
$106B
| $10.2M | 0.04% |
51,878
+4,578
| +10% | +$896K |
|
285
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
| $10.1M | 0.04% |
265,800
+127,300
| +92% | +$4.91M |
|
|
TWTR
286
DELISTED
Twitter, Inc.
TWTR
| $10.1M | 0.04% |
166,950
+14,211
| +9% | +$933K |
|
287
OptimizeRx
OPRX
$119M
| $10M | 0.04% |
116,840
+31,390
| +37% | +$1.97M |
|
288
Generac Holdings
GNRC
$11.5B
| $9.97M | 0.04% |
24,388
-8,815
| -27% | -$3.78M |
|
289
Public Service Enterprise Group
PEG
$39.3B
| $9.92M | 0.04% |
162,837
+14,369
| +10% | +$897K |
|
|
IPAXU
290
DELISTED
Inflection Point Acquisition Corp. Units
IPAXU
| $9.88M | 0.04% |
+1,000,000
| New | +$9.87M |
|
291
Sea Limited
SE
$65.8B
| $9.83M | 0.04% |
30,830
-2,653
| -8% | -$814K |
|
|
OKLO
292
Oklo
OKLO
$6.89B
| $9.82M | 0.04% |
+1,000,000
| New | +$9.87M |
|
293
Masco
MAS
$16.5B
| $9.71M | 0.04% |
174,829
+15,423
| +10% | +$915K |
|
294
Monster Beverage
MNST
$95.6B
| $9.7M | 0.04% |
218,378
+19,268
| +10% | +$911K |
|
295
PACCAR
PCAR
$72.7B
| $9.7M | 0.04% |
184,341
+16,266
| +10% | +$903K |
|
296
Newmont
NEM
$96.4B
| $9.66M | 0.04% |
177,966
+15,671
| +10% | +$924K |
|
297
AES
AES
$10.6B
| $9.62M | 0.04% |
421,178
+37,164
| +10% | +$903K |
|
|
CHNG
298
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $9.61M | 0.04% |
459,000
+90,000
| +24% | +$1.96M |
|
|
299
PUT
Amazon
AMZN
$2.48T
| $9.53M | 0.04% |
+58,000
| New | +$10M |
|
300
Expedia Group
EXPE
$35.5B
| $9.45M | 0.04% |
57,641
+5,086
| +10% | +$786K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.
- Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
- Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
- Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
- Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
- Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
- Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
- Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.
Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.